Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1526
BlackBerry
BB
$4.97B
| $5.96M | 0.01% |
+1,219,284
| New | +$5.51M |
2020 Q2
0 quarters
|
|
1527
TransUnion
TRU
$14B
| $5.96M | 0.01% |
68,500
-242,500
| -78% | -$19.4M |
2019 Q4
2 quarters
|
|
1528
Civeo
CVEO
$309M
| $5.94M | 0.01% |
803,204
-54,705
| -6% | -$337K |
2014 Q4
22 quarters
|
|
1529
Rafael Holdings
RFL
$77.5M
| $5.94M | 0.01% |
418,833
-24,843
| -6% | -$342K |
2018 Q1
9 quarters
|
|
1530
United Natural Foods
UNFI
$2.89B
| $5.93M | 0.01% |
325,650
+274,738
| +540% | +$4.12M |
2018 Q3
7 quarters
|
|
1531
StealthGas
GASS
$323M
| $5.93M | 0.01% |
2,156,054
-5,100
| -0.2% | -$12.5K |
2013 Q2
28 quarters
|
|
1532
PagSeguro Digital
PAGS
$3.05B
| $5.93M | 0.01% |
+167,745
| New | +$4.72M |
2020 Q2
0 quarters
|
|
1533
Editas Medicine
EDIT
$364M
| $5.92M | 0.01% |
200,100
-100,800
| -33% | -$2.63M |
2019 Q4
2 quarters
|
|
1534
Avient
AVNT
$3.6B
| $5.92M | 0.01% |
225,558
+85,700
| +61% | +$1.99M |
2016 Q1
17 quarters
|
|
1535
Titan Machinery
TITN
$537M
| $5.9M | 0.01% |
543,500
+142,700
| +36% | +$1.36M |
2016 Q4
14 quarters
|
|
1536
Graham Corp
GHM
$820M
| $5.89M | 0.01% |
462,596
+3,800
| +0.8% | +$46.4K |
2013 Q2
28 quarters
|
|
1537
Meritage Homes
MTH
$3.9B
| $5.88M | 0.01% |
154,400
+64,800
| +72% | +$1.91M |
2019 Q3
3 quarters
|
|
|
MIXT
1538
DELISTED
MIX TELEMATICS LIMITED
MIXT
| $5.87M | 0.01% |
680,400
+76,700
| +13% | +$676K |
2015 Q1
21 quarters
|
|
1539
SPX Corp
SPXC
$8.29B
| $5.86M | 0.01% |
142,400
-16,700
| -10% | -$629K |
2019 Q4
2 quarters
|
|
1540
Santander
BSBR
$42B
| $5.85M | 0.01% |
1,169,176
-996,184
| -46% | -$4.81M |
2017 Q1
13 quarters
|
|
1541
Amber International Holding Ltd
AMBR
$173M
| $5.84M | 0.01% |
109,534
+84,236
| +333% | +$4.16M |
2019 Q4
2 quarters
|
|
1542
Zumiez
ZUMZ
$222M
| $5.83M | 0.01% |
213,000
-20,100
| -9% | -$457K |
2018 Q1
9 quarters
|
|
1543
ARK Next Generation Technology ETF
ARKW
$2.21B
| $5.82M | 0.01% |
68,600
+40,342
| +143% | +$2.83M |
2020 Q1
1 quarter
|
|
1544
Capital City Bank Group
CCBG
$839M
| $5.82M | 0.01% |
277,691
-2,700
| -1% | -$53K |
2013 Q2
28 quarters
|
|
1545
Schwab US TIPS ETF
SCHP
$16.3B
| $5.82M | 0.01% |
+193,800
| New | +$5.74M |
2020 Q2
0 quarters
|
|
1546
Trade Desk
TTD
$6.15B
| $5.81M | 0.01% |
143,000
-1,678,580
| -92% | -$50.6M |
2018 Q1
9 quarters
|
|
1547
Crawford & Co Class B
CRD.B
$561M
| $5.8M | 0.01% |
825,417
+5,700
| +0.7% | +$36.1K |
2013 Q2
28 quarters
|
|
1548
Xenia Hotels & Resorts
XHR
$1.72B
| $5.8M | 0.01% |
621,300
+523,498
| +535% | +$4.88M |
2016 Q1
17 quarters
|
|
|
CORE
1549
DELISTED
Core Mark Holding Co., Inc.
CORE
| $5.75M | 0.01% |
230,400
+143,700
| +166% | +$3.85M |
2018 Q2
8 quarters
|
|
1550
InfuSystem Holdings
INFU
$278M
| $5.75M | 0.01% |
497,909
+18,901
| +4% | +$217K |
2015 Q4
18 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2020 Portfolio in Review
As of Q2 2020, Renaissance Technologies held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Renaissance Technologies withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,365 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Uber worth $187M.
- Renaissance Technologies's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Renaissance Technologies added most to Zoom in Q2 2020, an estimated $806M increase.
- Renaissance Technologies's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Renaissance Technologies fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Renaissance Technologies's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Renaissance Technologies opened 583 new positions and closed 596 in Q2 2020.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.